PETS (PetMed Express, Inc.) Stock Analysis - AI Report
PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of May 20, 2026, PETS trades at $2.18 with a market cap of $48.15M and a P/E ratio of -0.71. PETS moved +0.00% today. Year to date, PETS is -32.22%; over the trailing twelve months it is -44.53%. Its 52-week range spans $1.57 to $6.85. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on PETS?
Rallies AI research for PETS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Silvercape Investments Ltd bought 101.00K (~$320.17K) on Aug 13, 2025.
Silvercape Investments Ltd bought 118.20K (~$379.42K) on Aug 1, 2025.
NINA CAPITAL HOLDINGS INC. bought 25.00K (~$87.42K) on Jul 21, 2025.
PETS Analyst Consensus
PETS analyst coverage data. Average price target: $0.00.
Common questions about PETS
What is the AI research view on PETS?
Rallies AI research for PETS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for PETS?
Rallies AI research for PETS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is PETS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PETS. It does not provide personalized investment advice.
